Tag: Health

news-28112024-180523

Healing Spiritual Wounds: How to Overcome Spiritual Injury

As a doctor, Robert Klitzman knows that healthcare providers are well-prepared to address the physical needs of patients in hospitals, but may struggle with the emotional and spiritual challenges they face. This realization prompted...
news-28112024-120413

Understanding the Urgency of the BIOSECURE Act for Biosecurity Measures

The BIOSECURE Act, a piece of legislation targeting Chinese biotechnology companies, has been the center of attention in Washington early this year. However, the fate of this bill hangs in the balance as Congress...
news-28112024-060221

Building Resilient Healthcare: Vanessa Kerry’s Climate Change Mission

Vanessa Kerry, a physician specializing in pulmonary and critical care, established Seed Global Health over a decade ago to address disparities in healthcare systems worldwide, particularly in countries with limited resources. In a recent...
news-27112024-115756

Jim O’Neill Named HHS Deputy Secretary by Trump: Biotech Investor

President-elect Trump has selected biotech investor Jim O'Neill as the nominee for deputy secretary of the Health and Human Services department. If confirmed, O'Neill would be responsible for overseeing the day-to-day operations of various...
news-27112024-055630

Jay Bhattacharya: Trump’s Choice to Lead NIH

President-elect Trump has made his selection for the role of leading the National Institutes of Health known, with Stanford University professor Jay Bhattacharya being chosen for the position, as announced by his transition team...
news-26112024-115233

Roche Lung Cancer Study: Immunotherapy Failures and Drug Target Questions

Roche, a pharmaceutical company, recently announced that an experimental cancer treatment they were working on, called tiragolumab, did not improve survival rates in a major lung cancer study. The study, known as SKYSCRAPER-01, involved...
news-26112024-054957

Title: Analysis of Alector Therapeutics’ Alzheimer’s Treatment Failure in Phase 2 Study

Alector Therapeutics announced that their Phase 2 trial for a potential Alzheimer's antibody, known as AL002, was unsuccessful. This setback is disappointing as the drug was considered a promising approach to treating the neurodegenerative...
news-25112024-234610

The End of Cassava Sciences and its Alzheimer’s Drug: Lingering Damage

The story of Cassava Sciences came to a disappointing end on Monday when their experimental drug for Alzheimer's disease, simufilam, was found to be no more effective than a placebo in a large clinical...
news-22112024-142640

Optimistic Vaccine Activist: Embracing Hope for the Future

The United States is facing an uncertain future when it comes to vaccine policy. With potential appointees like Robert F. Kennedy Jr., Mehmet Oz, Jay Bhattacharya, and Joseph A. Ladapo, public health advocates are...
news-22112024-082138

Pfizer’s New R&D Head, VC Deep-Dive, and FDA Commissioner: What You Need to Know

Pfizer has welcomed a new R&D head, Chris Boshoff, who is expected to make significant strides in research and development to satisfy investors. Additionally, the biotech venture capital landscape is set to see some...
news-22112024-082107

FAQs: Understanding IGAs in Animals

Intentional Genomic Alterations (IGAs) in animals refer to changes made to an animal's DNA using modern molecular technologies. These alterations can include targeted DNA sequence changes like insertions, substitutions, or deletions, among others. Common...
news-21112024-183110

Novartis Acquires Kate Therapeutics to Advance Muscular Dystrophy Treatment

Novartis made a significant move in the field of gene therapy by acquiring Kate Therapeutics for up to $1.1 billion. This acquisition includes not only the gene therapy startup itself but also its drug...